08.01.2008 14:00:00

Exogen Signs Major Data Migration Contract

Exogen, a business solutions company focused on creating value for healthcare providers and manufacturers, and wholly-owned subsidiary of Technology Solutions Company (NASDAQ:TSCC), announced today that it was chosen by North Shore-Long Island Jewish Health System to manage the data migration and consolidation of medical image data from its legacy systems to their enterprise medical image storage system. Exogen’s Data Certainty solution combines its newly developed, patent-pending technology with its value focused professional services to provide the industry’s most comprehensive approach to analyzing, characterizing, cleansing and ensuring the migrating of legacy medical image data into a consolidated enterprise approach. "Exogen’s Data Certainty approach is unique,” commented John Bosco, Chief Information Officer, North Shore-LIJ Health System. "Unlike other data migration solutions we have used in the past or have investigated, Exogen takes a very holistic and complete approach to ensuring the integrity and migration of our data. Prior to moving one pixel of data, they were able to characterize our legacy data, tell us what was good and bad, what could be cleansed, and how fast the migration would take. This compares to the industry norm where vendors either provide you a piece of software to move the data yourself or worse, they begin moving data without regard to its integrity or impact to the organization.” "We are pleased to have been chosen by this prestigious Health System to assist them with their data management needs,” said Milton Silva-Craig, President and CEO of Exogen. "After several years of working with clients on data migration projects and developing a deep understanding of the challenges associated with migrating large amounts of proprietary and inconsistent data, we came to the realization that there were opportunities for significant improvements in innovation and process which would enhance the data migration experience resulting in more direct and tangible customer value creation. We look forward to helping North Shore-LIJ leverage their medical image data in a more meaningful manner.” ABOUT NORTH SHORE-LIJ HEALTH SYSTEM The nation's third largest, non-profit, secular healthcare system, the North Shore-LIJ Health System cares for people of all ages throughout Long Island, Queens and Staten Island – a service area encompassing more than five million people. Including its clinical affiliates, the health system consists of 16 hospitals, 13 long-term care facilities, a medical research institute, four trauma centers, five home health agencies and dozens of outpatient centers. The members and affiliates of North Shore-LIJ house more than 9,300 beds, and are staffed by over 8,000 physicians, about 11,000 nurses and a total workforce of more than 38,000 – the largest employer on Long Island and the ninth largest in New York City. ABOUT EXOGEN Exogen is a business solutions company that is focused on creating value for healthcare providers and manufacturers. Our solutions help lead the transformation of healthcare providers and manufacturers from a traditional inside-out thinking to an Outside-In value-driven customer perspective. Our teams of value creation experts have intimate knowledge of the challenges facing healthcare providers and manufacturers today and share a common vision for the future. We combine our knowledge and vision, with best-in-class solutions developed in other industries, to bring to market unique products and services for healthcare providers and manufacturers. We refer to our industry leading solutions as Experience and Certainty. Our proven Experience solutions leverage our exclusive Outside-In intellectual property helping our customers identify, understand and quantify value creation opportunities through the eyes of their customers. Our proven Certainty solutions deliver and sustain value in the areas of digital healthcare and operational transformation. Our entire suite of business solutions exist to deliver results. We have delivered hundreds of successful strategy, planning, implementation and optimization projects with extraordinary results and outstanding client references. For more information, please visit: www.exogeninc.com. Exogen is a wholly-owned subsidiary of Technology Solutions Company. ABOUT TSC Technology Solutions Company (TSC) is a leading business solutions provider that partners with clients to expose and leverage opportunities that create, measure, and sustain the delivery of value to their customers. TSC serves the healthcare and manufacturing industries. For more information, please visit: www.techsol.com. CERTAIN FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS This press release contains or may contain certain forward-looking statements concerning TSC’s financial position, results of operations, cash flows, business strategy, budgets, projected costs and plans and objectives of management for future operations as well as other statements including words such as "anticipate,” "believe,” "plan,” "estimate,” "expect,” "intend,” and other similar expressions. These forward-looking statements involve significant risks and uncertainties. Although TSC believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, readers are cautioned that no assurance can be given that such expectations will prove correct and that actual results and developments may differ materially from those conveyed in such forward-looking statements. TSC claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all forward-looking statements. Important factors that could cause actual results to differ materially from the expectations reflected in the forward-looking statements in this press release include, among others, TSC's ability to manage decreased revenue levels; TSC's need to attract new business and increase revenues; TSC's declining cash position; TSC's ability to manage costs and headcount relative to expected revenues; TSC's ability to successfully introduce new product and service offerings; TSC's ability to successfully introduce its new Exogen business subsidiary; TSC's dependence on a limited number of clients for a large portion of its revenue; the potential loss of significant clients; TSC's ability to attract new clients and sell additional work to existing clients; TSC's ability to attract and retain employees; the rapidly changing nature of information technology services, including TSC's ability to keep pace with technological and market changes and its ability to refine and add to existing service offerings; the lack of shareholder approved stock options available for grants by TSC to retain existing employees; and changing business, economic or market conditions and changes in competitive and other factors, all as more fully described herein and in TSC's filings with the Securities and Exchange Commission, press releases and other communications. Forward-looking statements are not guarantees of performance. Such forward-looking statements speak only as of the date on which they are made and, except as may be otherwise required by law, TSC does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release. If TSC does update or correct one or more forward-looking statements, investors and others should not conclude that TSC will make additional updates or corrections with respect thereto or with respect to other forward-looking statements. Actual results may vary materially.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Technology Solutions Co.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Technology Solutions Co.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Technology Solutions Co. 0,00 0,00% Technology Solutions Co.

Indizes in diesem Artikel

NASDAQ Comp. 19 054,84 0,27%